Task Group Charge
To identify and develop best practices for scalable screening models that also overcome barriers to the delivery of high quality lung cancer screening.
Leadership
Charles White, MD
Task Group Chair
University of Maryland
Peter Mazzone, MD, MPH
Task Group Vice Chair
Steering Committee Member
Cleveland Clinic
Task Group Members
Carolyn Aldigé
Prevent Cancer Foundation
Paul Doria-Rose, DVM, PhD*
National Cancer Institute
Debra Dyer, MD
National Jewish Health
Joelle Fathi, DNP, RN, ARNP, CTTS*
University of Washington School of Nursing
Laurie Fenton Ambrose*
GO2 Foundation for Lung Cancer
Grant Greenberg, MD, MHSA, MA
Lehigh Valley Health Network (Pennsylvania)
Claudia Henschke, PhD, MD
Icahn School of Medicine at Mount Sinai
Danny Hughes, PhD
Harvey L. Neiman Health Policy Institute
Jane Kim, MD, MPH*
Veterans Health Administration
Christopher Lathan, MD, MS, MPH
Dana-Farber Medical Institute at St. Elizabeth’s Medical Center
Bryan Loy, MD, MBA*
Humana
Andrea McKee, MD
Lahey/Beth Israel Lahey Health
James Mulshine, MD
Rush University Medical Center
Robert Nicklas
Life and Breath
Bruce Pyenson, FSA, MAAA
Milliman
Debra Ritzwoller, PhD
Kaiser Permanente
Lillie Shockney, RN, BS, MAS
Academy of Oncology Nurse and Patient Navigators
Carey Thomson, MD, MPH, FCCP
Mt. Auburn Hospital
Renda Wiener, MD, MPH
Boston University School of Medicine
Celeste Worth, MCHES
LuCa National Training Network
(*) indicates Steering Committee member
Opportunities for Intervention/Influence:
- Identify best practices/challenges in established lung cancer screening programs
- Define and regularly update alternative pathways and minimum standards to high quality lung cancer screening programs that include primary care, pulmonology, and radiology, and access to multidisciplinary groups
- Provide a forum for feedback from health plans, FQHCs, VA, other coverage groups